High Tower Advisors, LLC Ventyx Biosciences, Inc. Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 104,286 shares of VTYX stock, worth $158,514. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104,286
Previous 103,955
0.32%
Holding current value
$158,514
Previous $226,000
0.88%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VTYX
# of Institutions
134Shares Held
55.2MCall Options Held
81.4KPut Options Held
148K-
Black Rock Inc. New York, NY4.77MShares$7.25 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$6.81 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$6.5 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$6.15 Million3.31% of portfolio
-
Ubs Group Ag3.78MShares$5.75 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $85.9M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...